<DOC>
	<DOCNO>NCT02361645</DOCNO>
	<brief_summary>The purpose study assess vitreous concentration nonsteroidal antiinflammatory drug ( NSAIDs ) prostaglandin E2 patient treat NSAIDs vitrectomy . A total 0.5 1 mL undiluted vitreous remove midvitreous cavity begin surgery infusion balance salt solution . Samples immediately freeze store -40Â°C analysis . Samples evaluate masked fashion . Vitreous concentration study drug quantify use reverse-phase liquid chromatography mass spectroscopy system . The minimum quantification limit ketorolac , bromfenac , nepafenac , amfenac 0.8 ng/mL . Prostaglandin E2 concentration determine use commercially available competitive enzyme immunoassay kit ( R &amp; D Systems , Minneapolis , MN ) .</brief_summary>
	<brief_title>NSAIDs PGE2 Levels Vitrectomy Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>patient pucker schedule vitrectomy diabetes active inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>nonsteroidal antiinflammatory drug</keyword>
	<keyword>prostaglandin E2</keyword>
	<keyword>vitrectomy</keyword>
</DOC>